会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Immunochemical filter device and methods for use thereof
    • 免疫化学过滤装置及其使用方法
    • US20050277203A1
    • 2005-12-15
    • US10954627
    • 2004-09-29
    • Aimo Niskanen
    • Aimo Niskanen
    • C12M1/26C12M1/34G01N20060101G01N33/53G01N33/543
    • G01N33/5304Y10T436/25Y10T436/25375Y10T436/255
    • The invention provides an immunochemical filter device and use thereof, said filter device comprising a filter material attached to a support member. The filter material comprises a labeled binding reagent, wherein said labeled binding reagent is released from the filter material into solution by migration of a liquid sample solution through the filter material. The mixture of the sample solution and the labeled specific binding reagent is transferred to an analyzer device comprising a porous carrier, preferably by expressing the mixture through an aperture, diffusible membrane or valve in the support member. Additionally the invention provides a method for determining the presence or absence of an analyte in a sample solution and further provides a kit comprising the filter device.
    • 本发明提供一种免疫化学过滤装置及其用途,所述过滤装置包括附着于支撑构件的过滤材料。 过滤材料包括标记的结合试剂,其中所述标记的结合试剂通过液体样品溶液通过过滤材料迁移而从过滤材料释放到溶液中。 将样品溶液和标记的特异性结合试剂的混合物转移到包含多孔载体的分析装置中,优选通过将支持构件中的孔,扩散膜或阀表示混合物。 另外,本发明提供了一种用于确定样品溶液中分析物的存在或不存在的方法,并且还提供了包括过滤装置的试剂盒。
    • 3. 发明申请
    • Bacterial biosensors
    • 细菌生物传感器
    • US20050272105A1
    • 2005-12-08
    • US10888530
    • 2004-07-09
    • Kalle LevonBin YuYanxiu Zhou
    • Kalle LevonBin YuYanxiu Zhou
    • A61F13/15C12M1/34C12Q1/00G01N20060101G01N33/543G01N33/552G01N33/554G01N33/569
    • C12Q1/00C07K9/00C07K14/32C07K17/00C12Q1/003G01N33/53G01N33/54353G01N33/5438G01N33/54393G01N33/552
    • A real-time, portable peptide-containing potentiometric biosensor that can directly identify bacterial spores. Two peptides for specific recognition of B. subtilis and B. anthracis Sterne may be immobilized by a polysiloxane monolayer immobilization (PMI) technique. The sensors translate the biological recognition event into a potential change by detecting, for example, B. subtilis spores in a concentration range of 0.08-7.3×104 CFU/ml. The sensor exhibited highly selective recognition properties towards Bacillus subtilis spores over other kinds of spores. The selectivity coefficients of the sensors for other kinds of spores are in the range of 0-1.0×10−5. The biosensor system not only has the specificity to distinguish Bacillus subtilis spores in a mixture of B. subtilis and B. thuringiensis (thur.) Kurstaki spores, but also can discriminate between live and dead B. subtilis spores. Furthermore, the sensor can distinguish a Bacillus subtilis 1A700 from other B. subtilis strain. Assay time may be as low as about 5 minutes for a single test. Rapid identification of B. anthracis Sterne and B. anthracis ΔAmes was also provided.
    • 一种可直接鉴定细菌孢子的实时便携式含肽电位生物传感器。 用于特异性识别枯草芽孢杆菌和炭疽芽孢杆菌的两种肽可以通过聚硅氧烷单层固定(PMI)技术来固定。 传感器通过检测例如浓度范围为0.08-7.3×10 4 CFU / ml的枯草芽孢杆菌孢子将生物识别事件转化为潜在的变化。 传感器表现出对枯草芽孢杆菌孢子与其他种类孢子的高选择性识别性能。 用于其他种类孢子的传感器的选择性系数在0-1.0×10 -5的范围内。 生物传感器系统不仅具有将枯草芽孢杆菌和苏云金芽孢杆菌(thur。)Kurstaki孢子的混合物中的枯草芽孢杆菌孢子区分开的特异性,而且可以区分活枯枯病芽孢杆菌孢子和活枯草芽孢杆菌孢子。 此外,传感器可以将枯草芽孢杆菌1A700与其他枯草芽孢杆菌菌株区分开来。 单次测试的测定时间可能低至约5分钟。 炭疽杆菌和炭疽杆菌的快速鉴定也提供了DeltaAmes。
    • 7. 发明申请
    • Genotoxicity analysis
    • 遗传毒性分析
    • US20050221324A1
    • 2005-10-06
    • US10513489
    • 2003-05-06
    • Michael FoxCharles Waldren
    • Michael FoxCharles Waldren
    • C12N5/20C12N15/85C12Q1/68G01N20060101G01N33/50G01N33/566G01N33/569
    • G01N33/5014G01N33/566G01N33/56966G01N2333/70585G01N2333/70596
    • Genotoxicity testing can be carried out using a genetic hybrid cell line, for example, a CHO cell line which contains human chromosome 11. This exemplified hybrid cell line expresses human CD59 on the cell surface, and the human CD59 gene serves as a test for mutagenic agents. The hybrid cell line is grown in the presence of a test compound, and the loss of cell surface CD59 is followed using a fluorescent-labeled antibody specific for human CD59 and flow cytometry to monitor the presence or absence of labeled antibody on particular cells. Absence of the labeled antibody on the surface of the cells is indicative of a mutation in the CD59 gene such that either no CD59 protein is made or there has been a mutation which results in the loss of the antibody binding site. A test compound which causes CD59 loss is deemed to be genotoxic (i.e., mutagenic). The mutations can be point mutations, deletions, inversions, insertions, or frameshifts. The sensitivity of the assay is improved when the cells are first panned with antibody specific for the cell surface marker to remove spontaneous mutants prior to challenge with the test compound. Alternatively, or in addition, an antibiotic resistance marker is incorporated onto the same chromosome as the cell surface marker, and an antibiotic selection step precedes the challenge with the potential genotoxic composition or condition.
    • 可以使用遗传杂交细胞系,例如包含人染色体11的CHO细胞系进行基因毒性测试。这个例示的杂交细胞系在细胞表面表达人CD59,并且人CD59基因用作诱变的试验 代理商 杂交细胞系在受试化合物的存在下生长,并且使用针对人CD59特异性的荧光标记抗体和流式细胞术来监测细胞表面CD59的丧失,以监测特定细胞上标记抗体的存在或不存在。 在细胞表面没有标记的抗体指示CD59基因中的突变,使得不产生CD59蛋白,或者存在导致抗体结合位点丧失的突变。 造成CD59损失的试验化合物被认为是遗传毒性(即致突变性的)。 突变可以是点突变,缺失,倒置,插入或移码。 当细胞首先用针对细胞表面标志物的抗体特异性去除以在用测试化合物攻击之前去除自发突变体时,测定的灵敏度得到改善。 或者或另外,将抗生素抗性标记并入细胞表面标志物的相同染色体上,并且抗生素选择步骤在潜在的遗传毒性组合物或病症的攻击之前进行。